Description
General description
Rethink your bioinks with TissueFab®
About the material: Fibercoll-Flex-N(R) is a bioink formulated of pure, fibrillary collagen type I, making it ideal for printing highly biocompatible scaffolds with embedded cells.
Printing and crosslinking parameters:Made of acidic collagen fibers, the Fibercoll-Flex-N(R) is neutralized before printing, enabling the generation of bioprints with encapsulated cells at physiological conditions without a methacrylation curing step
Easy and efficient extrusion-based printing at room temperature or up to 37°C, no cooling devices for printer required
As the only fibrillary collagen bioinks on the market, the Fibercoll-Flex(R) collagen bioinks are composed of pure type I collagen fibers with high mechanical strength that enables easy printing and abets the need for artificial modification such as methacrylation or UV curing. The stable 3D models are highly biocompatible and represent in vivo like scaffolds of high shape fidelity for cell adherence and remodeling. The mechanical properties such as elastic modulus of the printed scaffolds can also be easily varied from 200-1000 Pa depending on collagen concentration. More information and a step by step protocol can be found under the "More Documents" section of this page.
Application
The Fibercoll-Flex-N® can be used for any bioprinting applications including: 3D cell culture in scaffolds of customized shape and stiffness
Complex tissue models
Tumor models
Tissue engineering and regenerative medicine
Cell based assays such as drug metabolism for drug discovery or drug screening applications
Features and Benefits
Key Features and Benefits: Each TissueFab(R) material is developed and tested to meet strict criteria to best suit researchers′ needs. This includes: Printability and fidelity
Cell viability
Biocompatibility
Sterility
Mechanical and rheological properties
Legal Information
TISSUEFAB is a registered trademark of Merck KGaA, Darmstadt, Germany
VISCOFAN FIBERCOLL-FLEX is a registered trademark of VISCOFAN, S.A.